Literature DB >> 28853134

Health-related quality of life of patients with asthma: a cross-sectional study in Semnan, Islamic Republic of Iran.

Naim S Kia1, Farhad Malek2, Elaheh Ghods1, Mona Fathi3.   

Abstract

Asthma can profoundly affect the quality of life of individuals with the disease. There are limited data on the quality of life of people with asthma in the Islamic Republic of Iran. This cross-sectional study aimed to evaluate quality of life in adults with asthma in Semnan using the 36-item short form health survey (SF-36). The effect of sociodemographic characteristics on quality of life scores was examined. The study included a convenience sample of 385 outpatients with asthma attending a pulmonary clinic from June to December 2013. The mean physical and mental component scores were 58.8 (SD 18.3) and 57.3 (SD 17.0) respectively. The study sample had lower quality of life scores in all the fields than the reference population (P < 0.05). Patients with lower education, urban residents, widowed/divorced patients and manual workers had lower quality of life scores (P < 0.05). Efforts are needed to improve the quality of life of people with asthma in parallel with precise management plans.

Entities:  

Mesh:

Year:  2017        PMID: 28853134     DOI: 10.26719/2017.23.7.500

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  2 in total

1.  The Relationship Between Sleep Quality and Quality of Life Among Patients With Asthma.

Authors:  Farhad Malek; Shokufe Khalil Sayah; Naim Sadat Kia; Elahe Ghods
Journal:  Cureus       Date:  2022-03-22

Review 2.  General health status in Iranian diabetic patients assessed by short-form-36 questionnaire: a systematic review and meta-analysis.

Authors:  Masoud Behzadifar; Rahim Sohrabi; Roghayeh Mohammadibakhsh; Morteza Salemi; Sharare Taheri Moghadam; Masood Taheri Mirghaedm; Meysam Behzadifar; Hamid Reza Baradaran; Nicola Luigi Bragazzi
Journal:  BMC Endocr Disord       Date:  2018-05-31       Impact factor: 2.763

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.